Literature DB >> 12482549

The atheroprotective effect of 17 beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice.

P Gourdy1, Z Mallat, C Castano, B Garmy-Susini, J L Mac Gregor, A Tedgui, J F Arnal, F Bayard.   

Abstract

The mechanisms that mediate the atheroprotective properties of estrogens remain obscure. In the present study, we evaluated the involvement of the adhesion molecule P-selectin, intercellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1) in the atheroprotective effect of estrogens in murine models evaluating early steps of atherosclerosis. First, we studied the effect of 17 beta-estradiol (E2) administration for 12 weeks on fatty streak constitution at the root aorta of ovariectomized female mice deficient in apolipoprotein E (apoE) alone or deficient in both apoE and either P-selectin or ICAM-1. Compared with respective placebo groups, E2 significantly prevented the development of fatty streak, to a similar extent in all three genotypes (-70.0% in apoE(-/-), -77.4% in apoE(-/-) P-selectin(-/-), and -77.1% in apoE(-/-) ICAM-1(-/-)). Second, the endothelial expression of VCAM-1 at the root aorta was assessed by immunohistochemistry in either placebo or E2-treated ovariectomized C57BL/6 female mice fed an atherogenic diet. Compared with placebo, E2 treatment resulted in a 31.8% decrease of VCAM-1 endothelial expression at this lesion-prone site (P=0.03). These results demonstrate that P-selectin and ICAM-1 are not involved in the atheroprotective effect of estrogens, and suggest that VCAM-1 could play a role in this process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482549     DOI: 10.1016/s0021-9150(02)00322-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

Review 1.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

2.  Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing.

Authors:  Audrey Billon-Galés; Andrée Krust; Coralie Fontaine; Anne Abot; Gilles Flouriot; Céline Toutain; Hortense Berges; Alain-Pierre Gadeau; Françoise Lenfant; Pierre Gourdy; Pierre Chambon; Jean-François Arnal
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

Review 3.  Sexual dimorphism in rodent models of hypertension and atherosclerosis.

Authors:  Kristen J Bubb; Rayomand S Khambata; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Suppression of endothelial P-selectin expression contributes to reduced cell trafficking in females: an effect independent of NO and prostacyclin.

Authors:  Inmaculada C Villar; Ramona S Scotland; Rayomand S Khambata; Melissa Chan; Johan Duchene; Andre L Sampaio; Mauro Perretti; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.